Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Ryerson University

$25,000.00

Typing and Targeting Mechanisms of RNA Decay Caused by Drug Treatment

EF 2017-18

Résumé
A Toronto-based company, Rna Diagnostics, has developed a test that determines whether chemotherapy isworking. The test is based upon the level of RNA disruption in a tumour sample, and its computationalanalysis. RNA is copied from DNA, and increased RNA can help to cause tumour growth in cancer. RNAdecay is a signal that chemotherapy is working and that tumour cells are dying. However, Rna Diagnosticswould like to understand the pathways that cause RNA decay, and whether different levels of RNA disruptionmean different drug effects or outcome.Dr. Sarah Sabatinos (Ryerson University, Toronto) will use yeast cellsto test how RNA disruption happens after drug treatment. The Sabatinos lab will use microscopy to understandhow RNA disruption happens, and test whether additional marks of chemotherapy effectiveness are present.Our combined goal is to make Rna Diagnostics' tool better able to predict tumour cell death, and work earlierafter drug is given. This work is important to promote training and improve diagnostics and predictivecomputational tools in Canada.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
516354-2017
Name nom
Sabatinos, Sarah
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
1
Application title
Typing and Targeting Mechanisms of RNA Decay Caused by Drug Treatment
Keyword
NSERC
Application summary
A Toronto-based company, Rna Diagnostics, has developed a test that determines whether chemotherapy isworking. The test is based upon the level of RNA disruption in a tumour sample, and its computationalanalysis. RNA is copied from DNA, and increased RNA can help to cause tumour growth in cancer. RNAdecay is a signal that chemotherapy is working and that tumour cells are dying. However, Rna Diagnosticswould like to understand the pathways that cause RNA decay, and whether different levels of RNA disruptionmean different drug effects or outcome.Dr. Sarah Sabatinos (Ryerson University, Toronto) will use yeast cellsto test how RNA disruption happens after drug treatment. The Sabatinos lab will use microscopy to understandhow RNA disruption happens, and test whether additional marks of chemotherapy effectiveness are present.Our combined goal is to make Rna Diagnostics' tool better able to predict tumour cell death, and work earlierafter drug is given. This work is important to promote training and improve diagnostics and predictivecomputational tools in Canada.